Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
advocate, announced, Arcion, AstraZeneca, AVANIR, Dainippon, declared, depositary, eligible, EpiCept, excessive, GlaxSmithKline, Greece, GW, Incentive, investor, Ireland, judgement, margin, Merz, methodology, nonclinical, Nordisk, Novo, outlined, plc, Portugal, registration, Relevare, SA, sequential, shelf, sNDA, SpA, Squibb, Srl, suitable, supplemental, tiered, unanticipated, unwilling, WEX, write, Xenoport
Removed:
analyzed, Anesiva, creating, diabetic, GlaxoSmithKline, saleable, standard
Filing tables
Filing exhibits
Related press release
NGSX similar filings
Filing view
External links